LMR Partners’s Halozyme HALO Stock Holding History

LMR Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-74,500	Closed	-$2.95M	–	1179
2022 Q3	$2.95M	Buy	+74,500	New	+$3.29M	0.05%	413

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's HALO Position: Q4 2022 in Review

LMR Partners sold out of Halozyme (HALO) in Q4 2022, closing a stake of 74,500 shares — an estimated $2.95M sold.

LMR Partners first reported a position in HALO in Q3 2022 and held it in 1 quarter. The position peaked at $2.95M in Q3 2022. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

LMR Partners reported no remaining Halozyme position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 74,500 Halozyme shares in Q4 2022, an estimated $2.95M.
LMR Partners first reported a position in Halozyme in Q3 2022 and held it in 1 quarter.
LMR Partners's Halozyme position peaked at $2.95M in Q3 2022.
423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.